Boston-based pharmaceutical company Karuna Pharmaceuticals has secured $68 million in Series B funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced March 18 and led by ARCH Venture Partners.
According to its Crunchbase profile, "Karuna Pharmaceuticals Inc. engages in development of drugs for the treatment of schizophrenia. The company was incorporated in 2009 and is based in Boston."
The 10-year-old company has raised three previous funding rounds, including a $42 million Series A round in 2018.
The round brings total funding raised by Boston companies in science and engineering over the past month to $209 million. The local science and engineering industry has seen 74 funding rounds over the past year, securing a total of $1.7 billion in venture funding.
In other local funding news, consulting and legal company LinkSquares announced a $4.8 million seed funding round on March 7, led by MassMutual Ventures.
According to Crunchbase, LinkSquares "built software that automatically reads and retrieves key data from your entire library of agreements, making review and diligence projects lightning fast and super simple."
The company also raised a $2.1 million seed round in 2017.
Meanwhile, insurance and personal finance company Catch raised $150,000 in seed funding, announced on March 18. The round was financed by Y Combinator.
From the company's Crunchbase profile, "Catch is redesigning benefits to put people at the center of their own financial stability and security. For freelancers, contractors and workers without access to employer benefits, Catch automatically handles tax withholding, builds long-term investment savings and provides critical insurance products."
Catch last raised $1 million in pre-seed funding earlier this year.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
